Sunday 18 October 2026
Export APMD’s income statement to Excel — free account
Apnimed, Inc.
APMD
Apnimed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, up 380.1% from fiscal 2024. Insiders bought in the last twelve months.
17.76
0.49
−2.68%
Follow APMD
| Dec '25 | Dec '24 | |
|---|---|---|
P/E ratio |
1.27 | 1.27 |
P/S ratio |
1.02 | 1.02 |
Altman Z″-Score (non-manufacturers) |
(29.54) | (13.94) |
P/FCF ratio |
0.00 | 0.00 |
Beneish M-Score |
0.00 | — |
P/Operating CF |
(6.62) | (6.62) |
P/B ratio |
0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.23 | 0.23 |
EV/EBITDA |
1.15 | 1.15 |
EV/Operating CF |
(0.32) | (0.32) |
EV/FCF |
(0.32) | (0.32) |
Quick Ratio |
0.39 | 1.64 |
Current Ratio |
0.41 | 1.73 |
Net Debt/EBITDA |
0.02 | 0.60 |
Debt/Assets |
55.78% | 0.00% |
Debt/Equity |
(0.11) | 0.00 |
Asset Turnover |
0.42 | 0.00 |
Operating CF/Net income |
0.61 | 0.99 |
Capex/Depreciation |
0.00 | (3.04) |
| 41.26% | 0.00% | |
| (140.79%) | 0.00% | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
194.95% | (359.28%) |
Average Days of Receivables |
9.10 | 50.80 |
Research and Development Expense of Revenue |
161.44% | 1,215.36% |
Selling, General and Administrative Expense of Revenue |
61.07% | 268.37% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
10.16% | 37.84% |
Graham Net Nets |
(1.56) | (1.56) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
78.92% | 78.92% |
Free Cash Flow Yield |
(69.83%) | (69.83%) |
Revenue per Share |
8.08 | 1.69 |
Operating CF per Share |
(16.34) | (23.23) |
Capex per Share |
0.00 | (0.01) |
Free Cash Flow per Share |
(16.34) | (23.25) |
Cash per Share |
8.79 | 14.41 |
Shareholders Equity per Share |
(78.27) | (52.41) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(78.27) | (52.41) |
Free Cash Flow |
(77.83) | (110.28) |
Working Capital |
(65.82) | 30.89 |
Capital Expenditures |
— | (0.07) |
Net Current Asset Value |
(400.60) | (284.59) |
EV/EBIT |
1.15 | 1.15 |
Capex to Sales |
0.00 | 0.01 |
Price to Operating Income |
5.15 | 5.15 |
| Other line items | ||
Depreciation/Fixed assets |
0.41 | 0.25 |
Cash ROIC |
26.82% | 61.18% |
Accounts Receivable Turnover |
37.09 | 0.00 |
Accounts Payable Turnover |
2.49 | 0.00 |
Inventory Turnover |
0.00 | 0.00 |
Average Days of Payables |
97.49 | 388.40 |
Days of Inventory on Hand |
0.00 | 0.00 |
Average Receivables |
1.04 | — |
Average Payables |
2.69 | — |
Average Assets |
91.05 | — |
Average Common Equity |
(310.70) | — |
Columns are period end dates · fundamentals updated 7 Oct 2026